Morgan Stanley Procaps Group, S.A. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Procaps Group, S.A. stock. As of the latest transaction made, Morgan Stanley holds 100 shares of PROC stock, worth $178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$178
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PROC
# of Institutions
9Shares Held
195KCall Options Held
0Put Options Held
0-
Exome Asset Management LLC New York, NY129KShares$230,1550.76% of portfolio
-
Geode Capital Management, LLC Boston, MA28.9KShares$51,5090.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$24,9200.64% of portfolio
-
State Street Corp Boston, MA12.4KShares$22,0410.0% of portfolio
-
Activest Wealth Management10KShares$17,8000.01% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $201M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...